These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 21145322

  • 21. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H, Yasar B, Ozkara S, Serdar MA, Kurdas OO, Gonen C.
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [Abstract] [Full Text] [Related]

  • 22. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
    Deghady A, Abdou A, El-Neanaey WA, Diab I.
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
    [Abstract] [Full Text] [Related]

  • 23. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM, Farid K, Emran TM, Attallah AA.
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [Abstract] [Full Text] [Related]

  • 24. YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis.
    Rath T, Roderfeld M, Güler C, Wenzel C, Graf J, Beitinger F, Roeb E, Zachoval R.
    Scand J Gastroenterol; 2011 Nov; 46(11):1369-80. PubMed ID: 21905976
    [Abstract] [Full Text] [Related]

  • 25. [The diagnostic value of eight serum indices for liver fibrosis].
    Cai WM, Zhang BB, Weng HL, Hu ZR, Lv J, Zheng M, Liu RH.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Apr; 12(4):219-22. PubMed ID: 15099471
    [Abstract] [Full Text] [Related]

  • 26. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM, Sohn JH, Kim TY, Roh YW, Eun CS, Jeon YC, Han DS, Oh YH.
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [Abstract] [Full Text] [Related]

  • 27. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Leung DH, Khan M, Minard CG, Guffey D, Ramm LE, Clouston AD, Miller G, Lewindon PJ, Shepherd RW, Ramm GA.
    Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
    [Abstract] [Full Text] [Related]

  • 28. The PAPAS index: a novel index for the prediction of hepatitis C-related fibrosis.
    Ozel BD, Poyrazoğlu OK, Karaman A, Karaman H, Altinkaya E, Sevinç E, Zararsiz G.
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):895-900. PubMed ID: 25951491
    [Abstract] [Full Text] [Related]

  • 29. Assessing liver fibrosis: comparison of arterial enhancement fraction and diffusion-weighted imaging.
    Bonekamp D, Bonekamp S, Ou HY, Torbenson MS, Corona-Villalobos CP, Mezey E, Kamel IR.
    J Magn Reson Imaging; 2014 Nov; 40(5):1137-46. PubMed ID: 24989329
    [Abstract] [Full Text] [Related]

  • 30. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
    McPherson S, Hardy T, Dufour JF, Petta S, Romero-Gomez M, Allison M, Oliveira CP, Francque S, Van Gaal L, Schattenberg JM, Tiniakos D, Burt A, Bugianesi E, Ratziu V, Day CP, Anstee QM.
    Am J Gastroenterol; 2017 May; 112(5):740-751. PubMed ID: 27725647
    [Abstract] [Full Text] [Related]

  • 31. Comparison of acoustic radiation force impulse/serum noninvasive markers for fibrosis prediction in liver transplant.
    Pinto J, Matos H, Nobre S, Cipriano MA, Marques M, Pereira JM, Gonçalves I, Noruegas MJ.
    J Pediatr Gastroenterol Nutr; 2014 Mar; 58(3):382-6. PubMed ID: 24164902
    [Abstract] [Full Text] [Related]

  • 32. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, Kim JK, Paik YH, Lee KS, Park YN, Han KH.
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [Abstract] [Full Text] [Related]

  • 33. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE.
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [Abstract] [Full Text] [Related]

  • 34. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
    Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH.
    J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
    [Abstract] [Full Text] [Related]

  • 35. [A clinical study on combined serum hepatic fibrosis-related markers and ultrasound parameters to diagnose hepatic fibrosis].
    Yu J, Jia CH, Wang Q, Xu PS, Zhang H, Zhao YQ, Shen Q, Hao YR, Cai GF.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):56-8. PubMed ID: 17429537
    [Abstract] [Full Text] [Related]

  • 36. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, Oncul O, Gorenek L.
    Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
    [Abstract] [Full Text] [Related]

  • 37. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER, Oliveira AC, Figueiredo-Mendes C, Lanzoni V, Martins J, Nader H, Ferraz ML.
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [Abstract] [Full Text] [Related]

  • 38. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients.
    Eminler AT, Ayyildiz T, Irak K, Kiyici M, Gurel S, Dolar E, Gulten M, Nak SG.
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1361-6. PubMed ID: 26352130
    [Abstract] [Full Text] [Related]

  • 39. The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
    Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ.
    J Hepatol; 2013 Aug; 59(2):236-42. PubMed ID: 23523583
    [Abstract] [Full Text] [Related]

  • 40. Development of Serum Marker Models to Increase Diagnostic Accuracy of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: The New LINKI Algorithm Compared with Established Algorithms.
    Lykiardopoulos B, Hagström H, Fredrikson M, Ignatova S, Stål P, Hultcrantz R, Ekstedt M, Kechagias S.
    PLoS One; 2016 Aug; 11(12):e0167776. PubMed ID: 27936091
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.